Enzon Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
DEFA14A: Enzon Pharmaceuticals Sets Date for 2024 Annual Stockholder Meeting, Outlines Key Proposals
Enzon Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders on September 26, 2024, to vote on director elections, auditor ratification, executive compensation, and an amendment to the Section 382 Rights Agreement.
OQB
Enzon Pharmaceuticals will hold its 2024 annual meeting on September 26, 2024, to vote on director elections, ratification of the accounting firm, executive compensation, and an extension to the Section 382 Rights Agreement.